Holen Sie sich die Stockscreener-App
145.22
0.56%
0.815
Handel nachbörslich:
145.50
0.275
+0.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Action challenging Commission’s jurisdiction over Grail’s acquisition of Illumina, published in OJ - EU Law Live
Illumina Inc. stock (US4523271090): Focus shifts to core sequencing business after divesting GRAIL - AD HOC NEWS
How Adding Diagnostics Veteran David King To The Board At Illumina (ILMN) Has Changed Its Investment Story - simplywall.st
Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential with a 33.82% ROE - DirectorsTalk Interviews
ILMN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Illumina stock (US4523271090): institutional buying meets cautious analyst outlook - AD HOC NEWS
Illumina Summit Highlights Multi-Omics Potential in India - Deccan Chronicle
Illumina (NASDAQ: ILMN) director Susan Siegel receives 2,072-share RSU grant - Stock Titan
Illumina (ILMN) awards 2,072 restricted stock units to director - Stock Titan
Illumina (ILMN) director Scott B. Ullem receives 2,072-share RSU award - Stock Titan
Illumina (ILMN) director Philip Schiller receives 2,072-share restricted stock grant - Stock Titan
Illumina (ILMN) director Anna Richo granted 2,072 restricted stock units as equity pay - Stock Titan
Illumina (ILMN) director Keith Meister granted 2,072 RSUs and updates holdings - Stock Titan
Illumina (ILMN) director Scott Gottlieb receives 2,072-share RSU grant - Stock Titan
Illumina (ILMN) director David P. King submits initial Form 3 - Stock Titan
Illumina’s SWOT analysis: stock faces visibility concerns despite growth By Investing.com - Investing.com Canada
Illumina’s SWOT analysis: stock faces visibility concerns despite growth - Investing.com
ILMN Stock Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina adds former Labcorp CEO to board of directors - Investing.com UK
Understanding Momentum Shifts in (ILMN) - Stock Traders Daily
Illumina adds former Labcorp CEO to board of directors By Investing.com - Investing.com South Africa
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
David P. King elected to Illumina's Board of Directors - Illumina
ILMN: All proposals were preliminarily approved, with no questions raised during the Q&A session - TradingView
DNA Methylation Sequencing Market to Reach USD 5.49 Billion - openPR.com
NGS-Based RNA Sequencing Market to Reach USD 15.0 Billion by 2033 - openPR.com
Illumina stock (US4523271090): corporate responsibility push after return to growth - AD HOC NEWS
Illumina stock (US4523271090): Corporate Responsibility Report highlights genomics growth drivers - AD HOC NEWS
Is This the Right Time to Retain ILMN Stock in Your Portfolio? - Yahoo Finance
Illumina stock (US4523271090): new responsibility report highlights growth drivers in genomics - AD HOC NEWS
Earnings Beat, Buyback, China Signals Might Change The Case For Investing In Illumina (ILMN) - Yahoo Finance
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR Newswire
SomaLogic Inc stock (US82489T1043): Illumina takeover reshapes proteomics story - AD HOC NEWS
Illumina stock (US4523271090): analysts see limited upside after volatile Nasdaq recovery - AD HOC NEWS
Illumina price tries to vent off overbought saturationForecast today18-05-2026 - Economies.com
NXP, Illumina, StoneX Group: Momentum Stocks Analysis (Buy & Sell)May 2026News and Statistics - IndexBox
Illumina stock (US4523271090): analysts see limited upside after recent volatility - AD HOC NEWS
Illumina stock (US4523271090): analysts see limited upside after volatile trading - AD HOC NEWS
Illumina Inc stock (US4523271090): spin-off progress and earnings keep investors alert - AD HOC NEWS
Illumina, Inc. Trade Ideas — EUROTLX:4ILMN - TradingView
SomaLogic Inc stock (US82489T1043): Illumina merger closes and reshapes proteomics story - AD HOC NEWS
Illumina Inc stock (US4523271090): gene sequencing player in focus after latest earnings and divesti - AD HOC NEWS
Illumina's new connected multiomics platform set to boost its stock - MSN
Illumina CEO Joins Trump-Xi Summit: Here’s What It Means for ILMN Stock - TIKR.com
MFS Blended Research Mid Cap Equity Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina, Inc.Common Stock (Nasdaq:ILMN) Stock Quote - FinancialContent
Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says - Moomoo
Swiss Life Asset Management Ltd Sells 47,498 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina Insider Sold Shares Worth $47,931,975, According to a Recent SEC Filing - marketscreener.com
Illumina stock (US4523271090): gene sequencing player in focus after leadership and strategy updates - AD HOC NEWS
RBC Capital Mkts resumed coverage on Illumina with a new price target - Quantisnow
Is Illumina (ILMN) Pricing Look Interesting After 77% One Year Share Price Gain - Yahoo Finance
Illumina (ILMN) Coverage Resumed with Outperform Rating and $170 Target - GuruFocus
Illumina director Keith Meister sells $47.9m in shares - Investing.com India
Illumina director Keith Meister sells $47.9m in shares By Investing.com - Investing.com Nigeria
Illumina(ILMN.US) Director Sells US$47.93 Million in Common Stock - Moomoo
Corvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan
RBC Capital assumes Illumina stock coverage with outperform rating By Investing.com - Investing.com Australia
RBC Capital assumes Illumina stock coverage with outperform rating - Investing.com
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
[SCHEDULE 13G/A] ILLUMINA, INC. Amended Passive Investment Disclosure - Stock Titan
Illumina stock (US4523271090): Shares up 10.6% YTD amid strong earnings beat - AD HOC NEWS
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.
Bioinformatics Market Trends, Investment Opportunities, and Growth Analysis Through 2033 | Affymetrix Inc, - EIN News
Here Are Thursday’s Top Wall Street Analyst Research Calls: Commercial Metals, Doximity, Draftkings, Hut 8, Illumina, Lowe’s, TeraWulf, Starbucks, Whirlpool, Wix.com, and More - Yahoo Finance
Daiwa Securities Upgrades Illumina to Outperform From Neutral, Adjusts Price Target to $155 From $128 - marketscreener.com
Bioinformatics Platforms Market Is Going to Boom | • Illumina Inc • Thermo Fisher Scientific Inc • QIAGEN N.V - openPR.com
0.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):